Remy Biosciences creates vital medicines and supplements with its transdermal and sublingual technology platforms to provide safe and highly effective controlled-dose delivery systems.

We advance science and lives through biodermal and sublingual technology.

Remy knows that there is a better way to deliver active ingredients into the body and, by doing so, achieve better wellness for all.

Learn More

Research and Development

Remy provides a powerful patent-protected delivery platform for some of the most effective drugs and supplements available.

Intellectual Portfolio

Our 6 granted US patents, in combination with our pending, provisional, and international IP portfolio grant us exclusive freedoms to operate in large sectors of the transdermal and sublingual space.

Manufacturing

Our proprietary, pharmaceutical-grade machinery is specifically designed to manufacture our best-in-class patches. Production is overseen and executed by an experienced team of chemists and engineers. Our quality control far exceeds industry standards, and it shows in the products we make.

Our Patents

Scroll to learn about Remy's IP journey

YEAR

2018

US Patent 9,962,340

Our foundational transdermal patent establishes exclusive rights for Polyisobutylene and amine-compatible silicone adhesive-based monolithic and reservoir patches delivering Cannabinoids

YEAR

2019

US Patent 10,272,125

Another foundational patent that broadens the scope of our exclusive rights surrounding the transdermal delivery of CBD, including the use of gelling agents, permeation enhancers, reservoir embodiments and membranes.

News

Remy Biosciences: Embarking on a Global Healthcare Revolution with Strategic Licensing Agreement with Datarocx Inc.

Read more in our Press Release Here

Remy Biosciences Unveils Trio of Pioneering Transdermal Patches, Offering Groundbreaking Solutions for Menstrual Cramps, General Pain Relief, and Psilocybin Therapy

Read more in our Press Release Here